Company Filing History:
Years Active: 2016
Title: Evert Nicolaas Lamme: Innovator in Interferon-beta Compositions
Introduction
Evert Nicolaas Lamme is a notable inventor based in Nyon, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic compositions.
Latest Patents
Lamme holds a patent for "IFN-beta compositions, preparation methods and uses thereof." This invention pertains to interferon-beta (IFN-beta) compositions that include a grafted poly(glutamic acid) polymer. The polymer has an average molecular weight between 26,000 and 40,000 g/mol and is grafted with alpha-tocopherol substituents. The average molar grafting ratio is between 4.5-5.5 moles %, and the weight/weight ratio between the grafted polymer and IFN-beta ranges from 24 to 125. The invention also covers the preparation methods of these compositions and their application in creating therapeutic compositions that deliver IFN-beta over an extended period.
Career Highlights
Evert Nicolaas Lamme is associated with Ares Trading S.a., where he continues to innovate in the field of biotechnology. His work focuses on enhancing the efficacy of therapeutic compositions, which can significantly impact patient care.
Collaborations
Lamme collaborates with talented individuals such as Daniel Leblanc and Helen Gabriela Baldascini. Their combined expertise contributes to the advancement of their projects and innovations.
Conclusion
Evert Nicolaas Lamme is a distinguished inventor whose work in interferon-beta compositions showcases his commitment to advancing medical science. His contributions are poised to make a lasting impact in the field of biotechnology.